26.01.2016 - Financial results of Johnson & Johnson suffered in connection with the strengthening of the dollar

Johnson & Johnson company reported for the 4th quarter of 2015. According to report the sales for the period fell by 2.4% compared to the same period of 2014, to 17.8 billion US dollars. The reason for the decline was the weak results from abroad, where sales were down 11.7%, against the background of foreign exchange factors. On the other hand, sales in the United States increased by 8.0%. During 2015 sales in the world totaled 70.1 billion dollars. Net profit for the 4th quarter was 3.2 billion dollars. Given the strong financial performance, which was negatively impacted currency fluctuations, we expect the growth of the company's shares by 18-20% per year.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.